Publications by Fehnle, K.

Heidemann, E., Stoeger, H., Souchon, R., Hirschmann, W.-D., Bodenstein, H., Oberhoff, C., Fischer, J. T., Schulze, M., Clemens, M., Andreesen, Reinhard, Mahlke, M., König, M., Scharl, A., Fehnle, K. and Kaufmann, M. (2002) Is first-line single-agent mitoxantrone in the treatment of high-risk metastatic breast cancer patients as effective as combination chemotherapy? No difference in survival but higher quality of life were found in a multicenter randomized trial. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 13 (11), pp. 1717-29. Fulltext not available.